Since DREAM serves as a Ca2+-sensor transcription factor in neurons, it can also participate in the progression of several neurodegenerative disorders, including Alzheimer’s (AD) and Huntington’s (HD) disease, and amyotrophic lateral sclerosis (ALS). This evidence concerns the gene KCNIP3 and amyotrophic lateral sclerosis.